Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (81-90 of 662) with videos related to

Pageof 67
Sort By:
AIDS Research and Therapy|August 20, 2005
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionMagnus Gisslén, Lars Rosengren, Lars Hagberg, et al.
AIDS (London, England)|September 9, 2004
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimenJohn Friend, Neil Parkin, Teri Liegler, et al.
Nature Immunology|February 25, 2022
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responsesJeffrey A Tomalka, Mehul S Suthar, Steven G Deeks, et al.
Mayo Clinic Proceedings|March 5, 2022
Findings From Mayo Clinic's Post-COVID Clinic: PASC Phenotypes Vary by Sex and Degree of IL-6 ElevationMatthew S Durstenfeld, Priscilla Y Hsue, Michael J Peluso, et al.
AIDS (London, England)|January 25, 2002
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G Deeks, Jason D Barbour, Robert M Grant, et al.
Lancet (London, England)|June 7, 2005
Multidrug-resistant, dual-tropic HIV-1 and rapid progressionDouglas F Nixon, Steven G Deeks, Barbara L Shacklett, et al.
Plos One|September 30, 2009
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapyMichael Rosenblum, Steven G Deeks, Mark van der Laan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
HIV-induced changes in T cell signaling pathwaysMarc Schweneker, David Favre, Jeffrey N Martin, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIVDeepti Kannan, Eric Wang, Steven G Deeks, et al.
Cell Reports|November 16, 2025
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIVDeepti Kannan, Eric Wang, Steven G Deeks, et al.
Pageof 67

Showing results (81-90 of 662) with videos related to

Sort By:
Pageof 67
AIDS Research and Therapy|August 20, 2005
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionMagnus Gisslén, Lars Rosengren, Lars Hagberg, et al.
AIDS (London, England)|September 9, 2004
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimenJohn Friend, Neil Parkin, Teri Liegler, et al.
Nature Immunology|February 25, 2022
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responsesJeffrey A Tomalka, Mehul S Suthar, Steven G Deeks, et al.
Mayo Clinic Proceedings|March 5, 2022
Findings From Mayo Clinic's Post-COVID Clinic: PASC Phenotypes Vary by Sex and Degree of IL-6 ElevationMatthew S Durstenfeld, Priscilla Y Hsue, Michael J Peluso, et al.
AIDS (London, England)|January 25, 2002
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G Deeks, Jason D Barbour, Robert M Grant, et al.
Lancet (London, England)|June 7, 2005
Multidrug-resistant, dual-tropic HIV-1 and rapid progressionDouglas F Nixon, Steven G Deeks, Barbara L Shacklett, et al.
Plos One|September 30, 2009
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapyMichael Rosenblum, Steven G Deeks, Mark van der Laan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
HIV-induced changes in T cell signaling pathwaysMarc Schweneker, David Favre, Jeffrey N Martin, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIVDeepti Kannan, Eric Wang, Steven G Deeks, et al.
Cell Reports|November 16, 2025
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIVDeepti Kannan, Eric Wang, Steven G Deeks, et al.
Pageof 67